Form 4 for PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-06 · accession 0001299130-24-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-06 | 2024-03-06 | PACB | Meline David W | Dir | P - Purchase | $4.40 | +40.0K | 40.0K | New | +$176.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-06 | P | A | 40,000 | $4.40 | 40,000 | D | — | — | (F1) This purchase price represents the weighted average purchase price of the shares acquired ranging from $4.38 to $4.44 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. |